Immunoexpression of lactoferrin in human sporadic renal cell carcinomas

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1021-1026

  Giuffrè, Giuseppe ^a   Barresi, Valeria ^a   Skliros, Christodoulos ^a   Barresi, Gaetano ^a   Tuccari, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

3p region; Immunohistochemistry; Lactoferrin; Renal carcinoma

Indexed keywords

LACTOFERRIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LACTOFERRIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34548585487     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1021     Document Type: Article

References (49)

1. Steijns JM and van Hooijdonk ACM: Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. Br J Nutr 84: 11-17, 2000.
2. Masson PL, Heremans JF and Dire CH: An iron-binding protein common to many external secretions. Clin Chim Acta 14: 735-739, 1966.
3. De Vet BJCM and van Gool J: Lactoferrin and iron absorption in the small intestine. Acta Med Scand 196: 393-402, 1974.
4. Mason DY and Taylor CR: Distribution of transferrin, ferritin and lactoferrin human tissues. J Clin Pathol 31: 316-327, 1978. (Pubitemid 8315980)
5. Brock J: Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant. Arch Dis Child 55: 417-421, 1980.
6. Reitamo S, Kontinnen YT and Segerber-Kontinnen M: Distribution of lactoferrin in human salivary glands. Histochemistry 66: 285-291, 1980. (Pubitemid 10057401)
7. Korsrud FR and Brandtzaeg P: Characterization of epithelial elements in human major salivary glands by functional markers: localization of amylase, lactoferrin, lysozyme, secretory component, and secretory immunoglobulins by paired immunofluorescence staining. J Histochem Cytochem 30: 657-666, 1982. (Pubitemid 13224408)
8. Caselitz J, Jaup T and Seifert G: Lactoferrin and lysozyme in carcinomas of the parotid gland. Virchows Arch (A) 394: 61-73, 1981.
9. Barresi G and Tuccari G: Lactoferrin in benign hypertrophy and carcinomas of the prostatic gland. Virchows Arch (A) 403: 59-66, 1984. (Pubitemid 14103985)
10. Rossiello R, Carriero MV and Giordano GO: Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue. J Clin Pathol 37: 51-55, 1984.
11. Charpin C, Lachard A, Pourreau-Schneider N, et al: Localization of lactoferrin and non-specific cross-reacting antigen in human breast carcinomas. Cancer 55: 2612-2617, 1985.
12. Tuccari G and Barresi G: Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas. Virchows Arch (A) 406: 67-74, 1985. (Pubitemid 15083762)
13. Barresi G and Tuccari G: Iron-binding proteins in thyroid tumours. An immunocytochemical study. Path Res Pract 182: 344-351, 1987. (Pubitemid 17111039)
14. Loughlin KR, Gittes RF and Partridge D: The relationship of lactoferrin to the anemia of renal carcinoma. Cancer 59: 566-571, 1987. (Pubitemid 17002440)
15. Tuccari G, Barresi G. Arena F and Inferrera C: Immnno-cytochemical detection of lactoferrin in human gastric carcinomas and adenomas. Arch Pathol Lab Med 113: 912-916, 1989.
16. Cabaret V, Vilain MO, Delobelle-Deroide A and Vanseymortier L: Détection immunohistochimique de la céruloplasmine et de la lactoferrine sur une sèrie de 59 tumeurs thyroidiennes. Ann Pathol 12: 347-352, 1992. (Pubitemid 23079917)
17. Tuccari G, Rizzo A, Crisafulli C and Barresi G: Iron-binding proteins in human colorectal adenomas and carcinomas: an immunocytochemical investigation. Histol Histopathol 7: 543-547, 1992.
18. Asato de Camargo RY, Longatto Filho A, Ferreira Alves VA, Bisi H, Takami Kanamura C and Alves Abelin NM: Lactoferrin in thyroid lesions. Immunoreactivity in fine needle aspiration biopsy samples. Acta Cytol 40: 408-413, 1996.
19. Tuccari G. Rossiello R and Barresi G: Iron binding proteins in gallbladder carcinomas. An immunocytochemical investigation. Histol Histopathol 12: 671-676, 1997. (Pubitemid 27314698)
20. Tuccari G, Giuffrè G, Crisafulli C and Barresi G: Immuno-histochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. Eur J Histochem 43: 317-322, 1999. (Pubitemid 30052189)
21. Tuccari G, Giuffrè G, Scarfi R, Simone A, Todaro P and Barresi G: Immunolocalization of lactoferrin in surgically resected pigmented skin lesions. Eur J Histochem 49: 33-38, 2005.
22. Giuffrè G, Arena F, Scarfì R, Simone A, Todaro P and Tuccari G: Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormones receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival. Oncol Rep 16: 257-263, 2006.
23. Eble JN, Sauter G, Epstein JI and Sesterhenn IA (eds): Pathology and genetics of tumours of the urinary system and male genital organs. In: World Health Organization Classification of Tumours. IARC Press, Lyon, 2004.
24. Weir EE, Pretlow TG and Pitts A: A more sensitive and specific histochemical peroxidase stain for the localization of cellular antigen by the enzyme-antibody conjugate method. J Histochem Cytochem 22: 1135-1140, 1974.
25. Douglas-Jones AG, Schmid KW, Bier B, et al: Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol 26: 217-222, 1995.
26. Tuccari U, Giuffrè G, Arena F and Barrcsi G: Immuno-histochemical detection of metallothionein in carcinomatous and normal human gastric mucosa. Histol Histopathol 15: 1035-1041, 2000.
27. Garrè C, Bianchi-Scarra U, Sirito M, Musso M and Ravazzolo R: Lactoferrin binding sites and nuclear localization in K562(S) cells. J Cell Physiol 153: 477-482, 1992.
28. Penco S. Scarfì S, Giovine M, et al: Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 34: 151-159, 2001. (Pubitemid 33152512)
29. Van Berkel PHC, van Veen HA, Geerts MEJ and Nuijens JH: Characterization of monoclonal antibodies against human lactoferrin. J Immunol Methods 267: 139-150, 2002. (Pubitemid 34880028)
30. Brock J: Lactoferrin: a multifunctional immunoregolatory protein? Immunol Today 16: 417-419, 1995.
31. Defer MC, Dugas B, Picard O and Damais C: Impairment of circulating lactoferrin in HIV-1 infection. Cell Mol Biol 41: 417-421, 1995.
32. Fujihara T and Hayashi K: Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch Virol 140: 1469-1472, 1995.
33. Levay PF and Viljoen M: Lactoferrin: a general review. Haematologica 80: 252-267, 1995.
34. Lonnerdal B and Lyer S: Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15: 93-110, 1995.
35. Ikeda M, Sugiyama K, Tanaka T, et al: Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem Biophys Res Commun 245: 549-553, 1998. (Pubitemid 28418543)
36. Tanaka K, Ikeda M, Nozaki A, et al: Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn J Cancer Res 90: 367-371, 1999. (Pubitemid 29213539)
37. Tuccari G, Villari D, Giuffrè G. et al: Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease. Histol Histopathol 17: 1077-1083, 2002.
38. McCombs JL, Teng CT, Pentecost BT, et al: Chromosomal localization of human lactotransferrin gene (LTF) by in situ hybridization. Cytogenet Cell Genet 47: 16-17, 1988.
39. Yang Y, Li J, Szeles A, Imreh MP, Kost-Alimova M, Kiss H, Kholodnyuk I, Fedorova L, Darai E, Klein G and Imreh S: Consistent down-regulation of human lactoferrin gene, in the common eliminated region 1 on 3p21.3, following tumour growth in severe combined immunodeficient (SCID) mice. Cancer Lett 191: 155-164, 2003. (Pubitemid 36255600)
40. Kholodnyuk ID, Kozireva S. Kost-Alimova M, Kashuba V, Klein G and Imreh S: Down-regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice. Int J Cancer 119: 99-107, 2006.
41. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Muller-Brechlin R, Klein G and Sumegi J: Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85: 1571-1575, 1988. (Pubitemid 18070801)
42. Roiron D, Amouric M, Marvaldi J and Figarella C: Lactoferrin-binding sites at the surface of HT29-D4 cells. Eur J Biochem 186: 367-373, 1989.
43. Iacopetta BJ, Morgan EH and Yeoh GCT: Receptor-mediated endocytosis of transferrin by developing erythroid cells from the fetal rat liver. J Histochem Cytochem 31: 336-344, 1983. (Pubitemid 13039737)
44. Damiens E, Mazurier J, El Yazidi I, et al: Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim Biophys Acta 1402: 277-287, 1998. (Pubitemid 28206922)
45. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G and Boilly-Marer Y: Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74: 486-498, 1999. (Pubitemid 29344898)
46. Norrby K, Mattsby-Baltzer I, Innocenti M and Tuneberg S: Orally administered bovine lactoferrin systematically inhibits VEGF(165)-mediated angiogenesis in the rat. Int J Cancer 91: 236-240, 2001. (Pubitemid 32041746)
47. Weinberg ED: Iron withholding: a defense against infection and neoplasia. Physiol Rev 64: 65-102, 1984.
48. Shoji A and Ozawa E: Necessity of transferrin for RNA synthesis in chick myotubes. S Cell Physiol 127: 349-356, 1986. (Pubitemid 16065385)
49. Van Snick JL, Masson PL and Heremans JF: The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med 140: 1068-1084, 1974.